EUCTR2005-004849-33-GB
Active, not recruiting
Phase 1
Prevention of oesophagitis, gastric and duodenal lesions in patients taking antithrombotic low-dose aspirin with famotidine
HS Greater Glasgow0 sites700 target enrollmentStarted: November 29, 2005Last updated:
DrugsPepcid
Overview
- Phase
- Phase 1
- Status
- Active, not recruiting
- Sponsor
- HS Greater Glasgow
- Enrollment
- 700
Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Adult patients, aged 18 years or over, using low\-dose aspirin (75\-325 mg daily) for vascular protection
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range
- •F.1\.3 Elderly (\>\=65 years) yes
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •Unstable or uncontrolled cardiovascular or systemic diseases. Significant endoscopic abnormalities at base\-line endoscopy
Investigators
Similar Trials
Unknown
Phase 2
ong-term administration study of E3810 for the prevention of gastric or duodenal ulcer caused by low-dose aspiriJPRN-jRCT2080221500Eisai Co., Ltd.300
Unknown
Phase 2
Efficacy of E3810 for the prevention of gastric or duodenal ulcer caused by low-dose aspiriGastric or duodenal ulcers caused by low-dose aspirinJPRN-jRCT2080221499Eisai Co., Ltd.450
Recruiting
Not Applicable
Prevention of gastrointestinal complications by infusion pump in patients receiving enteral nutritioInpatients receiving enteral nutrition via nasogastric tube, gastric fistula, or intestinal fistulaJPRN-UMIN000005609Division of Clinical pharmacokinetics, Faculty of Pharmacy, Keio University200
Recruiting
Phase 4
It is the study to compare non surgical treatment modality for gastroduodenal obstructioCTRI/2020/07/026501SMS Hospital and medical college
Completed
Not Applicable
Optimal treatment strategy for esophago-gastric junctional cancerEsophago-gastric junctional cancerJPRN-UMIN000008596Digestive Disease Center, Showa University Nothern Yokohama Hospital200